Christopher Trevor Ritchlin, M.D.
See information for Patients. Viewing information for Researchers.
Contact
University of Rochester
School of Medicine and Dentistry
601 Elmwood Ave, Box 695
Rochester, New York 14642
Office: 585 273-2125
Lab: 585 273-2124
Fax: 585 442-3214

Current Appointments
- Professor - Department of Medicine (SMD)
| Education | ||
|---|---|---|
| MPH Public Health & Clinical Investigation | University of Rochester | 2008 |
| MD Medicine | Albany Medical College | 1982 |
| BA Biology | University of Rochester | 1976 |
| B.A. History | University Of Rochester | 1976 |
| Post-Doctoral Training & Residency | |
|---|---|
| Matriculated MPH University of Rochester School of Medicine and Dentistry Rochester, NY 14642 | 2001 - 2008 |
| Research Fellow Shriner's Hospital Montreal, Canada | 1990 - 1991 |
| Fellow NYU Hospitals Center New York, NY 10016 | 1986 - 1989 |
| Chief Resident Internal Medicine Mount Sinai Hospital New York, NY | 1985 - 1986 |
| Resident, Internal Medicine Mount Sinai Hospital New York, NY | 1983 - 1986 |
| Intern Internal Medicine Albany Medical Center Albany, NY | 1982 - 1983 |
| Fellowship Awards | |
|---|---|
| Henry Christian Award for Excellence in Clinical Research American Federation of Clinical Research | 1991 |
| Alpha Omega Alpha Albany Medical College | 1981 |
| Stanley Poole Award for Excellence in Internal Medicine Albany Medical College | |
Lab Description
Efforts are focused on the mechanisms of bone resorption and formation, the effect of anti-TNF agents on dendritic cell differentiation and the mechanisms for bone marrow edema in PsA and RA.
Lab Website
http://dev.mc.rochester.edu/medicine/allergy/research/RitchlinLab.cfm
| Recent Journal Articles |
|---|
| Showing the 5 most recent journal articles. (81 available) |
| Anandarajah AP; Schwarz EM; Totterman S; Monu J; Feng CY; Shao T; Haas-Smith SA; Ritchlin CT. "The effect of etanercept on osteoclast precursor frequency and enhancing bone marrow oedema in patients with psoriatic arthritis." Annals of the rheumatic diseases. 2008; 67(3):296-301. Epub 2007 Oct 29. |
| Proulx, S.T.; Kwok, E.; You, Z.; Papuga, M.O.; Beck, C.A.; Shealy, D.J.; Ritchlin, C.T.; Awad, H.A.; Boyce, B.F.; Xing, L.; Schwarz, E.M. "Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography". Arthritis & Rheumatism 56 (2007): 4024-4037. |
| Kavanaugh, A.; Ritchlin, C.; Boehncke, W.H. "Quality indicators in psoriatic arthritis". Clinical & Experimental Rheumatology 25 (2007): 98-101. |
| Gladman DD; Mease PJ; Ritchlin CT; Choy EH; Sharp JT; Ory PA; Perdok RJ; Sasso EH. "Adalimumab for long-term treatment of psoriatic arthritis: forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial." Arthritis and rheumatism. 2007; 56(2):476-88. |
| Pariser DM; Bagel J; Gelfand JM; Korman NJ; Ritchlin CT; Strober BE; Van Voorhees AS; Young M; Rittenberg S; Lebwohl MG; Horn EJ; . "National Psoriasis Foundation clinical consensus on disease severity." Archives of dermatology. 2007; 143(2):239-42. |

